Steven Quake. Founder of single-cell genomics He pioneered microfluidics and single-cell analysis. His work advanced personalized medicine and genomics. In 1969, he was born in the USA. In 1991, he earned his PhD in Physics from Stanford University. In 2007, he founded Fluidigm to commercialize single-cell genomics. 1. Single-cell genomics, a method to study DNA […]
Carl June. Co-founder of CAR-T cell therapy He developed CAR-T therapy to fight cancer. His work transformed immunotherapy for blood cancers. In 1953, he was born in the USA. In 1977, he earned his MD from the University of North Carolina at Chapel Hill. In 2012, he co-developed the first effective CAR-T therapy. 1. CAR-T
Jim Allison. Co-founder of Immuno-oncology therapies He pioneered immune checkpoint therapy for cancer. His work revolutionised cancer treatment. In 1948, he was born in the USA. In 1973, he earned his PhD in Biochemistry from the University of Texas. In 1994, he discovered CTLA-4 blockade for cancer therapy. 1. Immune checkpoint therapy, a method that
Daphne Koller. Co-founder of Insitro She pioneers the use of AI in drug discovery. Her work bridges computer science and biotechnology. In 1968, she was born in Israel. In 1995, she earned her PhD in Computer Science from Stanford University. In 2018, she co-founded Insitro. 1. AI-driven drug discovery, a method that uses machine learning
Uğur Şahin. Co-founder of BioNTech He advanced mRNA-based cancer immunotherapy. His work helped deliver rapid vaccine solutions. In 1965, he was born in Turkey. In 1992, he earned his MD from the University of Cologne in Medicine. In 2008, he co-founded BioNTech. 1. mRNA immunotherapy, a technology that trains the immune system to fight disease.
Robert Langer. Founder of modern drug delivery systems He transformed how medicines reach the human body. His work bridges engineering and medicine. In 1948, he was born in the USA. In 1974, he earned his PhD from the Massachusetts Institute of Technology in Chemical Engineering. In 1976, he developed controlled drug delivery using polymer systems.
Frances Arnold. Inventor of directed evolution She pioneered a new way to engineer proteins. Her work changed chemistry and biotechnology. In 1956, she was born in the USA. In 1985, she earned her PhD in Chemical Engineering from the University of California, Berkeley. In 1993, she demonstrated directed evolution for improving enzymes. 1. Directed evolution,
Drew Weissman. Co-inventor of mRNA vaccines He helped make mRNA safe for human use. His work enabled rapid vaccine development. In 1959, he was born in the USA. In 1987, he earned his MD and PhD from Boston University School of Medicine. In 2005, he co-discovered a method to modify mRNA to reduce immune reactions.
Katalin Karikó. Co-inventor of mRNA therapeutics She pioneered messenger RNA for medicine. Her work enabled rapid vaccine development. In 1955, she was born in Hungary. In 1982, she earned her PhD from the University of Szeged in Biochemistry. In 2005, she co-published the key discovery that made mRNA safe for human use. 1. mRNA therapeutics,
J. Craig Venter. Founder of Celera Genomics. He is a pioneer of genome sequencing. His work accelerated human genome research. In 1946, he was born in the USA. In 1975, he graduated from the University of California, San Diego in Biochemistry. In 1998, he founded Celera Genomics. 1. Whole genome shotgun sequencing, a fast method
Feng Zhang. Co-founder of CRISPR genome editing He advanced CRISPR for use in human cells. His work pushed gene editing into medicine. In 1981, he was born in China. In 2009, he completed his PhD in Chemistry at Stanford University. In 2013, he helped develop CRISPR for use in mammalian cells. 1. CRISPR genome editing,
George Church. Founder of Personal Genome Project He pioneered genome sequencing and synthetic biology. His work is shaping the future of genetics. In 1954, he was born in the USA. In 1978, he graduated from Duke University with a degree in Chemistry. In 2005, he founded the Personal Genome Project to make human genome data
Emmanuelle Charpentier. Co-founder of CRISPR-Cas9. She co-discovered CRISPR-Cas9. It revolutionised gene editing globally. In 1968, she was born in France. In 1995, she completed her PhD in Microbiology at Pierre and Marie Curie University. In 2012, she co-discovered CRISPR-Cas9. 1. CRISPR-Cas9, a gene-editing tool that cuts and modifies DNA. 2. It offers hope for treating
Emmanuelle Charpentier Read More »
